Evgenia Andrianopoulou

Evgenia Andrianopoulou's work experience includes their current role as a Process Development API Scientist at DEMO Pharmaceuticals S.A. which started in May 2022. Previously, they completed their MSc Thesis at Ethnikon kai Kapodistriakon Panepistimion Athinon from February 2020 to July 2021, where they focused on the synthesis of thiazole derivatives as potential inhibitors of the urease enzyme. Prior to that, they also completed their BSc Thesis at the same institution from February 2019 to May 2019, where they investigated sequential cyclization/radical alkylation alpha-methylene-beta-phosphinylcar compounds.

Evgenia Andrianopoulou pursued their education at the Ethnikon kai Kapodistriakon Panepistimion Athinon, where they completed a Bachelor's degree in Chemistry from 2015 to 2019. Evgenia further pursued their studies at the same institution and obtained a Master of Science (MS) degree in Organic Chemistry from 2019 to 2021. Additionally, they have achieved additional certifications, including a C2 English certification from the Learning Resource Network in January 2022 and a B2 French certification from Université Paris-Sorbonne in December 2013.